EP1220682 - STABILIZED LIQUID POLYPEPTIDE-CONTAINING PHARMACEUTICAL COMPOSITIONS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.09.2007 Database last updated on 03.09.2024 | Most recent event Tooltip | 07.08.2009 | Lapse of the patent in a contracting state New state(s): CY | published on 09.09.2009 [2009/37] | Applicant(s) | For all designated states Novartis Vaccines and Diagnostics, Inc. 4560 Horton Street Emeryville, CA 94608 / US | [2006/36] |
Former [2002/28] | For all designated states CHIRON CORPORATION 4560 Horton Street Emeryville California 94608-2916 / US | Inventor(s) | 01 /
CHEN, Bao-Lu Intellectual Prop.-R440, P.O. Box 8097 Emeryville, CA 94622-8097 / US | 02 /
HORA, Maninder Intellectual Prop.-R440, P.O. Box8 097 Emeryville, CA 94622-8097 / US | [2002/28] | Representative(s) | Marshall, Cameron John Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
Former [2005/40] | Marshall, Cameron John Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB | ||
Former [2002/28] | UEXKÜLL & STOLBERG Patentanwälte Beselerstrasse 4 22607 Hamburg / DE | Application number, filing date | 00968584.3 | 03.10.2000 | [2002/28] | WO2000US27156 | Priority number, date | US19990157696P | 04.10.1999 Original published format: US 157696 P | [2002/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0124814 | Date: | 12.04.2001 | Language: | EN | [2001/15] | Type: | A1 Application with search report | No.: | EP1220682 | Date: | 10.07.2002 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.04.2001 takes the place of the publication of the European patent application. | [2002/28] | Type: | B1 Patent specification | No.: | EP1220682 | Date: | 22.11.2006 | Language: | EN | [2006/47] | Search report(s) | International search report - published on: | EP | 12.04.2001 | Classification | IPC: | A61K38/20, A61K38/57, A61K38/21, A61K47/18 | [2002/28] | CPC data not yet available | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2006/47] |
Former [2002/28] | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | STABILISIERTE FLÜSSIGE PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND POLYPEPTIDE | [2002/28] | English: | STABILIZED LIQUID POLYPEPTIDE-CONTAINING PHARMACEUTICAL COMPOSITIONS | [2002/28] | French: | COMPOSITIONS PHARMACEUTIQUES LIQUIDES STABILISEES CONTENANT UN POLYPEPTIDE | [2002/28] | Entry into regional phase | 29.04.2002 | National basic fee paid | 29.04.2002 | Designation fee(s) paid | 29.04.2002 | Examination fee paid | Examination procedure | 03.05.2001 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 29.04.2002 | Examination requested [2002/28] | 13.09.2002 | Despatch of a communication from the examining division (Time limit: M09) | 23.06.2003 | Reply to a communication from the examining division | 21.01.2004 | Despatch of a communication from the examining division (Time limit: M06) | 02.08.2004 | Reply to a communication from the examining division | 04.03.2005 | Despatch of a communication from the examining division (Time limit: M06) | 16.08.2005 | Reply to a communication from the examining division | 10.03.2006 | Communication of intention to grant the patent | 18.07.2006 | Fee for grant paid | 18.07.2006 | Fee for publishing/printing paid | Divisional application(s) | EP04021066.8 / EP1491208 | Opposition(s) | 23.08.2007 | No opposition filed within time limit [2007/44] | Fees paid | Renewal fee | 29.04.2002 | Renewal fee patent year 03 | 23.10.2003 | Renewal fee patent year 04 | 25.10.2004 | Renewal fee patent year 05 | 07.10.2005 | Renewal fee patent year 06 | 05.10.2006 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 22.11.2006 | CY | 22.11.2006 | FI | 22.11.2006 | DK | 22.02.2007 | SE | 22.02.2007 | GR | 23.02.2007 | PT | 23.04.2007 | [2009/37] |
Former [2008/19] | AT | 22.11.2006 | |
FI | 22.11.2006 | ||
DK | 22.02.2007 | ||
SE | 22.02.2007 | ||
GR | 23.02.2007 | ||
PT | 23.04.2007 | ||
Former [2007/37] | AT | 22.11.2006 | |
FI | 22.11.2006 | ||
DK | 22.02.2007 | ||
SE | 22.02.2007 | ||
PT | 23.04.2007 | ||
Former [2007/36] | AT | 22.11.2006 | |
FI | 22.11.2006 | ||
SE | 22.02.2007 | ||
PT | 23.04.2007 | ||
Former [2007/28] | AT | 22.11.2006 | |
FI | 22.11.2006 | ||
SE | 22.02.2007 | ||
Former [2007/25] | FI | 22.11.2006 | |
SE | 22.02.2007 | Cited in | International search | [X]EP0229016 (SHIONOGI & CO [JP], et al) [X] 1-8,16,17,20,21,24-26,32-40 * page 2, line 31 - line 39 * * page 2, line 55 - page 3, line 25 * * page 4; example 2 * * page 5 - page 6; table 1 * * claims 1-8 *; | [X]US5078997 (HORA MANINDER S [US], et al) [X] 1-5,16,17,32-35,37,39,40 * column 2, line 17 - line 54 * * column 5, line 13 - line 17 * * column 5, line 31 - line 48 * * column 6, line 1 - line 10 * * column 6, line 30 - line 36 * * column 9 - column 10; example 3 * * column 10; example 4 * * claims 1-3,7-10,13,14 *; | [X] - BAO-LU CHEN; XIAORONG WU; SUSAN J. BABUKA; MANNINDER HORA, "Solubility of recombinant human tissue factor pathway inhibitor", JOURNAL OF PHARMACEUTICAL SCIENCES, (1999), vol. 88, no. 9, pages 881 - 888, XP000926223 [X] 1-6,12,16-21,24,25,30,32-40 * page 883, column 1, line 17 - column 2, line 14 * * page 884, column 1, line 47 - line 61 * * page 886, column 2, line 58 - line 65 * DOI: http://dx.doi.org/10.1021/js9900708 | [X] - CHANG B S ET AL, "DEVELOPMENT OF A STABEL FREEZE-DRIED FORMULATION OF RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST", PHARMACEUTICAL RESEARCH,US,NEW YORK, NY, (19960201), vol. 13, no. 2, ISSN 0724-8741, pages 243 - 249, XP000611612 [X] 1 * page 243, column 1, line 7 - line 30 * * page 248, column 2, line 4 - line 26 * DOI: http://dx.doi.org/10.1023/A:1016043114998 | Examination | EP0303746 | EP0508194 |